Effect of Glp-1 and Antidiabetic sgLT2 Agents for myoCardial infarcTion and Ultrasensitive Inflammatory Surveillance (GALACTUS Trial)

NCT07295223 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

44

Enrollment

OTHER_GOV

Sponsor class

Conditions

Acute Myocardial Infarction With ST Elevation

Interventions

DRUG: Dapagliflozin 10 MG Oral Tablet
DRUG: Semaglutide (Rybelsus®)

Sponsor

Instituto Mexicano del Seguro Social

Collaborators

[object Object]